Up Next
Back to Show
Amanpour & Co.
Is a New Treatment for Cancer on the Horizon? Moderna CEO Explains
A vaccine developed by drug companies Merck and Moderna has shown promising results in preventing melanoma from recurring. The vaccine relies on the same mRNA technology used to develop the COVID vaccine. It's the first time the technology has been used to target cancer and proves that personalized cancer vaccines can work. Noubar Afeyan, co-founder and Chairman of Moderna, discusses.
Support Provided By
Unlock with PBS Passport
55:46
Merav Michaeli; Nasser Al-Kidwa; Jeffrey Goldberg; John Williams and Anne-Sophie Mutter